dihexa photodegradation Photocatalytic degradation of organic dyes on magnetically separable barium hexaferrite as photocatalyst under conditions of Dihexa | CAS#:1401708-83-5 | Chemsrc

BMI, waist circumference, and waist-to-height ratio improved significantly with combination therapy

Drug Design, Development and Therapy, 13 , 27772786

The TRIUMPH-4 trial showed that retatrutide at 12mg reduced: Systolic blood pressure: 14.0 mmHg reduction Non-HDL cholesterol: clinically meaningful improvement High-sensitivity C-reactive protein: significant reduction (a marker of systemic inflammation) Triglycerides: substantial decrease Tirzepatide produces similar cardiovascular improvements, with well-documented reductions in blood pressure, triglycerides, and inflammatory markers across the SURMOUNT and SURPASS programs

These data support further investigation of CagriSema in people with type 2 diabetes in longer and larger phase 3 trials, Frias said